Carlos Brotons Selected Research

Acute Coronary Syndrome

1/2021

Practical Decision Algorithms for the Use of the Cardiovascular Polypill in Secondary Prevention in Europe.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carlos Brotons Research Topics

Disease

9	Cardiovascular Diseases (Cardiovascular Disease) 05/2021 - 08/2003
7	Hypertension (High Blood Pressure) 03/2021 - 08/2003
6	Type 2 Diabetes Mellitus (MODY) 10/2022 - 12/2013
5	Diabetes Mellitus 05/2023 - 10/2008
4	Coronary Disease (Coronary Heart Disease) 07/2019 - 10/2002
3	Chronic Kidney Failure (Chronic Renal Failure) 05/2023 - 03/2022
3	Chronic Renal Insufficiency 05/2023 - 03/2022
3	Vascular Diseases (Vascular Disease) 03/2021 - 09/2020
3	Insulin Resistance 09/2008 - 08/2003
2	COVID-19 11/2023 - 01/2021
2	Peripheral Arterial Disease 01/2021 - 03/2008
2	Stroke (Strokes) 01/2021 - 03/2008
2	Dyslipidemias (Dyslipidemia) 11/2019 - 03/2008
2	Hemorrhage 01/2018 - 04/2015
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2016 - 03/2008
2	Heart Failure 04/2009 - 03/2008
2	Obesity 10/2008 - 03/2008
1	Periodontitis 12/2024
1	Acute Coronary Syndrome 01/2021
1	Atrial Fibrillation 02/2020
1	Renal Insufficiency (Renal Failure) 07/2019
1	Albuminuria 01/2018
1	Alcoholism (Alcohol Abuse) 01/2018
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2018
1	Neoplasms (Cancer) 04/2015
1	Heart Diseases (Heart Disease) 11/2013
1	Hypercholesterolemia 10/2008
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2006
1	Abdominal Obesity 01/2006
1	Atherosclerosis 08/2003
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 08/2003
1	Myocardial Infarction 02/2003

Drug/Important Bio-Agent (IBA)

9	LipidsIBA 05/2023 - 01/2006
6	LDL CholesterolIBA 05/2023 - 03/2008
5	CholesterolIBA 11/2019 - 10/2008
3	AlbuminsIBA 05/2023 - 03/2022
3	CreatinineIBA 05/2023 - 03/2022
3	Metformin (Glucophage)FDA LinkGeneric 03/2021 - 09/2020
3	PCSK9 InhibitorsIBA 03/2021 - 09/2020
3	DNA Transposable Elements (Element, IS)IBA 03/2021 - 09/2020
3	oxidized low density lipoproteinIBA 01/2021 - 07/2009
3	Antihypertensive Agents (Antihypertensives)IBA 07/2019 - 03/2008
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018 - 08/2006
1	molnupiravirIBA 11/2023
1	Antiviral Agents (Antivirals)IBA 11/2023
1	Hemoglobins (Hemoglobin)IBA 10/2022
1	Triglycerides (Triacylglycerol)IBA 05/2021
1	Lipoproteins (Lipoprotein)IBA 03/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	AntibodiesIBA 01/2021
1	apixabanIBA 02/2020
1	HDL CholesterolIBA 07/2019
1	ProteomeIBA 01/2018
1	nalmefene (Revex)FDA Link 01/2018
1	Neprilysin (Neutral Endopeptidase)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2016
1	Blood Glucose (Blood Sugar)IBA 04/2012
1	Glucose (Dextrose)FDA LinkGeneric 09/2008
1	prednylidene (Pred)IBA 09/2008
1	LDL Lipoproteins (beta Lipoproteins)IBA 03/2008
1	2,5-dihydroxybenzene-1,4-disulfonic acid-bis(diethylamine) (263E)IBA 08/2006
1	LeptinIBA 08/2003

Therapy/Procedure

3	Glycemic Control 05/2023 - 03/2022
3	Secondary Prevention 01/2011 - 10/2002
1	Dental Care 12/2024
1	Therapeutics 01/2021
1	Polypharmacy 01/2021
1	Patient Readmission 04/2009
1	Drug Therapy (Chemotherapy) 02/2003